Clinical Trials Browser

Phase 1/2 × cabazitaxel × Tumor-Agnostic × Clear all

NCT01001221 2013-09-11

Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor

Phase 1/2 Terminated

19 enrolled 55 charts

Neoplasms